Featured Stories
Latest company news, announcements, and milestones from 4baseCare.
OncoTwin winner of Best Innovation in AI Health -At the AI Bharat Health Mission 2026
As Healthcare moves into an AI-first future, the real opportunity lies in making innovation clinically meaningful, accessible, and built for the populations we serve.Grateful to the organizers of AI Bharat Health Mission 2026 and BioSpectrum for bringing together leaders, innovators, and healthcare changemakers on one platform.
4baseCare announces close of its Series B round at ₹130 Cr ($14 Mn).
4baseCare announces close of its Series B round at ₹130 Cr ($14 Mn), co-led by investors Ashish Kacholia and Lashit Sanghvi, with participation from existing backers Yali Capital, Infosys & growX ventures.
4baseCare is proud to be enabling the LuNGS alliance driven by CRSF - Cancer Research and Statistic Foundation and supported by pharma companies like AstraZeneca, Roche, Eli Lilly and Company, Johnson & Johnson , Pfizer and Bristol Myers Squibb.
"It's not just about being good in science or the business, it's about how each and every life counts and doing our part towards the same.” - Kshitij Rishi. 4baseCare is proud to be enabling the LuNGS alliance driven by CRSF - Cancer Research and Statistic Foundation and supported by pharma companies like AstraZeneca, Roche, Eli Lilly and Company, Johnson & Johnson , Pfizer and Bristol Myers Squibb. We thank The Economic Times for the coverage.
4baseCare Bangalore Lab Achieves NABL Accreditation
4baseCare’s Bangalore lab has received NABL (ISO 15189) accreditation, recognizing its adherence to high standards in diagnostic quality and reliability. This milestone strengthens confidence in clinical decisions and reflects the collective efforts of multiple teams across the organization.
4baseCare signs MoU with Maharashtra Govt to establish Centre of Excellence for precision oncology
4baseCare has partnered with the Maharashtra government to establish a Centre of Excellence for precision oncology, integrating genomic-driven cancer care into the public health system. The centre will use NGS technology and the AI-powered OncoTwin platform to enable more personalised, data-driven treatment decisions.
4baseCare signs MoU with Bio Valley Incubation Council and Define Bio to build India’s next-gen genomics ecosystem at AMTZ
In a significant step towards building India's Next-Generation Genomics ecosystem, Bio Valley, 4baseCare and Define Bio (Biobank) have signed a Memorandum of Understanding (MoU) to establish a Center of Excellence (CoE) named BioSphere dedicated to Genomics and Next-Generation Sequencing (NGS) at Andhra Pradesh MedTech Zone (AMTZ), Vizag
We’re proud to share that our collaboration with OWKIN has been featured in GenomeWeb - one of the world’s most respected global publications in genomics and precision medicine.
Through this collaboration, we’re working to bridge that gap by contributing high-quality clinico-genomic insights from diverse populations and enabling more inclusive research and therapeutic discovery. Grateful to our teams, partners, and collaborators who continue to push the boundaries of science with purpose. Because better data doesn’t just advance research - it changes patient outcomes !
